10,861 Shares in Astera Labs, Inc. $ALAB Bought by Simplicity Wealth LLC

Simplicity Wealth LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,861 shares of the company’s stock, valued at approximately $2,127,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. State Street Corp grew its holdings in shares of Astera Labs by 39.3% during the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after buying an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. raised its position in Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Astera Labs by 46.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after acquiring an additional 479,360 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Astera Labs by 36.2% during the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after acquiring an additional 330,841 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 576,936 shares of company stock valued at $87,409,540 in the last three months. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 0.2%

Shares of ALAB opened at $176.35 on Friday. The company’s fifty day simple moving average is $161.29 and its 200 day simple moving average is $168.25. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The company has a market cap of $29.79 billion, a price-to-earnings ratio of 158.87, a PEG ratio of 2.40 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company’s quarterly revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ALAB. Royal Bank Of Canada started coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Needham & Company LLC raised their target price on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Northland Securities boosted their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $190.63.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.